|
|
||||||||
Papers In Press, published online ahead of print July 16, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pathology Dept., Wake Forest University School of Medicine, Winston-Salem, NC 27157
Corresponding Author: jparks{at}wfubmc.edu
Patients homozygous for Tangier disease have a near absence of plasma HDL due to mutations in ABCA1 and hypercatabolize normal HDL particles. To determine the relationship between ABCA1 expression and HDL catabolism, we investigated intravascular remodeling, plasma clearance, and organ-specific uptake of HDL in mice expressing the human apoA-I transgene (hA-I Tg) in the Abca1-/- knockout (KO) background. Small HDL particles (7.5 nm), radiolabeled with 125I-tyramine cellobiose, were injected into recipient mice to quantify plasma turnover and organ uptake of tracer. Small HDL tracer was remodeled to 8.2 nm diameter particles within 5 min in hA-I Tg mice (control) and KO mice. Decay of tracer from plasma was 1.6-fold more rapid in KO mice (p<0.05) and kidney uptake was twice that of controls, with no difference in liver uptake. We also observed a two-fold higher hepatic expression of ABCA1 protein in hA-I Tg mice, compared to non-transgenic mice, suggesting that overexpression of human apoA-I sta-bilized hepatic ABCA1 protein in vivo. We conclude that ABCA1 is not required for in vivo remodeling of small HDL to larger HDL subfractions and that hypercatabolism of normal HDL particles in KO mice is due to a selective catabolism of HDL apoA-I by the kidney.
Revised on July 5, 2005
Accepted on July 10, 2005
Plasma HDL in human apoA-I transgenic-Abca1 knockout mice undergo normal intravascular remodeling but are hypercatabolized by the kidney
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Mulya, J.-Y. Lee, A. K. Gebre, E. Y. Boudyguina, S.-K. Chung, T. L. Smith, P. L. Colvin, X.-C. Jiang, and J. S. Parks Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL J. Lipid Res., November 1, 2008; 49(11): 2390 - 2401. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhu, J.-Y. Lee, J. M. Timmins, J. M. Brown, E. Boudyguina, A. Mulya, A. K. Gebre, M. C. Willingham, E. M. Hiltbold, N. Mishra, et al. Increased Cellular Free Cholesterol in Macrophage-specific Abca1 Knock-out Mice Enhances Pro-inflammatory Response of Macrophages J. Biol. Chem., August 22, 2008; 283(34): 22930 - 22941. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Lee, R. M. Badeau, A. Mulya, E. Boudyguina, A. K. Gebre, T. L. Smith, and J. S. Parks Functional LCAT deficiency in human apolipoprotein A-I transgenic, SR-BI knockout mice J. Lipid Res., May 1, 2007; 48(5): 1052 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Owen, M. S. Bharadwaj, M. J. Thomas, S. Bhat, M. P. Samuel, and M. G. Sorci-Thomas Ratio determination of plasma wild-type and L159R apoA-I using mass spectrometry: tools for studying apoA-IFin J. Lipid Res., January 1, 2007; 48(1): 226 - 234. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |